Phase 1b/2a trial of HSB-888 in pediatric osteosarcoma
Latest Information Update: 02 Feb 2024
At a glance
- Drugs HSB-888 (Primary)
- Indications Osteosarcoma
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2020 New trial record
- 23 Nov 2020 According to a Hillstream Biopharma media release, company anticipate a rapid progression toward an IND and initiation of Phase 1b/2a trials